Precision with a Purpose: Benchmark 659 for Cancer Care - Powered by Twist Bioscience

Portrait de Vivek & Lynn
Présenté par
Dr Vivek Rathi (MD, MSc, FRCPA)
Dr Vivek Rathi (MD, MSc, FRCPA)
Directeur médical / anatomopathologiste moléculaire, LifeStrands Genomics Australia
Dre Lynn Fink (PhD, FFSc, RCPA (Pathology Informatics))
Dre Lynn Fink (PhD, FFSc, RCPA (Pathology Informatics))
Directrice de laboratoire, LifeStrands Genomics Australia

Abordés dans ce webinaire
Découvrez les progrès de pointe dans la recherche sur le cancer.
Découvrez comment les panels d’enrichissement ciblé de Twist fournissent aux oncologues et aux anatomopathologistes des données génomiques pertinentes pour la prise de décision.

In this webinar, you will hear from the team at LifeStrands Genomics Australia about their newly launched Benchmark 659, a NGS panel powered by Twist’s target enrichment technology. Twist’s target enrichment technology supports cancer research by identifying biomarkers for disease detection and characterisation.


You will learn the science behind the panel, real-world applications, and how Twist can support clinical researchers for cancer research. Whether you’re a treating clinician, molecular pathologist or scientist, or healthcare leader, this session will demonstrate how advanced genomics can be accessible, actionable, and centred around improving patient care.

Saisissez vos coordonnées pour regarder le webinaire

 

 

Powered by Translations.com GlobalLink Web Software